Repros Therapeutics (RPRX) Reports Q4 Loss of $0.16/Share
Tweet
Share
E-mailGet Alerts RPRX Hot Sheet
Price: $59.45 --0%
Financial Fact:
General and administrative: 997K
Today's EPS Names:
HSAI, SYRS, EGRX, More
Financial Fact:
General and administrative: 997K
Today's EPS Names:
HSAI, SYRS, EGRX, More
Join SI Premium – FREE
Repros Therapeutics (NASDAQ: RPRX) reported Q4 EPS of ($0.16), versus ($0.26) reported last year.
For earnings history and earnings-related data on Repros Therapeutics (RPRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Home Depot beats estimates, reaffirms fiscal 2026 guidance
- Prenetics IM8 revenue jumps 359% in Q2, raises FY2026 guidance
- Baidu (BIDU) Misses Q2 EPS by 262c, misses on revenue
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
